Receptor-Driven ERK Pulses Reconfigure MAPK Signaling and Enable Persistence of Drug-Adapted BRAF-Mutant Melanoma CellsLuca Gerosa, Peter K. Sorger, Mariya Atanasova et al.|Cell Systems|2020Cited by 117
Sporadic ERK pulses drive non-genetic resistance in drug-adapted BRAF <sup>V600E</sup> melanoma cellsLuca Gerosa, Peter K. Sorger, Christopher Chidley et al.|bioRxiv (Cold Spring Harbor Laboratory)|2019Cited by 6
Computational Modeling of Drug Response Identifies Mutant-Specific Constraints for Dosing panRAF and MEK Inhibitors in MelanomaAndrew Goetz, Luca Gerosa|Cancers|2024Cited by 3
Abstract LB-B09: ERK pulses drive non-genetic resistance in drug-adapted BRAFV600E melanoma cellsLuca Gerosa, Peter K. Sorger, Christopher Chidley et al.|Molecular Cancer Therapeutics|2019Cited by 0
Computational modeling of drug response identifies mutant-specific constraints for dosing panRAF and MEK inhibitors in melanomaAndrew Goetz, Luca Gerosa|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0